You’ve done the math. Branded Wegovy runs $1,300 or more per month out of pocket, insurance keeps denying the claim, and your doctor’s office has a six-week wait. You need something that actually ships, actually works with a real physician, and doesn’t empty a savings account. Here’s where the honest options stand right now.
A quick note before the table: compounded semaglutide and tirzepatide are not FDA-approved drugs. They’re prepared by licensed 503A pharmacies under state and federal pharmacy law, which is a different regulatory track. That matters, and every provider below should tell you that plainly.
Side-by-Side: The 10 Best Cash-Pay and Low-Cost GLP-1 Telehealth Picks
| # | Provider | Sema Starting Price | Tirz Starting Price | Ships To | Key Differentiator |
| 1 | HealthRX | ~$99/mo | ~$149/mo | All 50 states | Named 503A pharmacy, LegitScript-certified, free overnight shipping |
| 2 | FormBlends | ~$299/vial | ~$349/vial | 47 states | Published HPLC/mass spec/endotoxin purity data; peptide catalog |
| 3 | Mochi Health | ~$99/mo | ~$199/mo | Most states | Obesity-medicine board-certified MDs |
| 4 | Henry Meds | ~$179 month one | N/A | Most states | 24-72h shipping, cash-pay, light monitoring |
| 5 | Eden | ~$149/mo | N/A | Most states | Straightforward compounded sema, transparent pricing |
| 6 | MEDVi | ~$179 month one | N/A | Most states | No contracts, cash-pay compounded |
| 7 | Found | ~$99/mo platform | Meds separate | Most states | Platform + coaching combo |
| 8 | Ro Body | ~$39 first month | Meds separate | Most states | Prior-auth team, insurance navigation |
| 9 | PlushCare | ~$19.99/mo membership | Branded meds | Most states | Same-day visits, insurance-compatible |
| 10 | Hims & Hers | ~$249/mo oral | ~$299/mo injectable | All states | Now on branded meds post-Novo settlement |
The Standouts, Explained
1. HealthRX
The case for HealthRX is simple: it hits the lowest cash-pay entry price in this field while keeping the pharmacy chain traceable. Compounded semaglutide starts at $99 a month. Compounded tirzepatide starts at $149. Those are real numbers, not teaser rates that balloon at checkout.
The pharmacy doing the dispensing is Manifest Pharmacy in Greer, South Carolina, a 503A facility operating under USP-797 standards with lot-tracked production. That specificity matters. A lot of compounding telehealth providers don’t name their pharmacy at all. HealthRX also holds LegitScript certification (certificate 50087439), which is an independent credentialing check, not a self-awarded badge. Physician review takes roughly 24 hours, and free overnight shipping reaches all 50 states.
The clinical reference points the brand cites come from published trials: the SURMOUNT-1 data showing roughly 21% mean body weight reduction at 72 weeks for tirzepatide, and STEP 1 data showing roughly 15% at 68 weeks for semaglutide. Those are trial-population averages, not guarantees.
Best for: the cost-conscious buyer who wants a named, credentialed pharmacy and all-state access without monthly membership fees.
2. FormBlends
FormBlends earns the second slot for a specific type of buyer, not everyone. The pricing is higher than HealthRX: semaglutide runs around $299 per vial and tirzepatide around $349. What you’re paying for is transparency at the batch level. FormBlends publishes purity testing results including HPLC purity percentages, mass spec identity confirmation, and endotoxin and sterility data, by product. Most GLP-1 telehealth brands offer none of that.
The other differentiator: FormBlends operates a broader peptide catalog covering recovery, longevity, and cognitive compounds, all under the same clinician-oversight model. If you want one provider for GLP-1 therapy plus other peptide protocols, FormBlends is the only name on this list set up for that. Ships to 47 states.
Best for: the detail-oriented buyer willing to pay more for published batch-level purity data, or someone who wants GLP-1s and peptides from one clinician relationship.
3. Mochi Health
Mochi Health pairs its $99/mo compounded semaglutide with access to physicians who hold board certification in obesity medicine. That’s a genuine clinical distinction. Tirzepatide runs $199/mo. The monitoring is heavier than some cash-pay-only services.
4. Henry Meds
Henry Meds keeps it fast and cash-only. Month one compounded semaglutide runs roughly $179, shipping arrives in 24 to 72 hours, and there’s no insurance paperwork to wrestle with. Monitoring is lighter than Mochi, which suits some people and not others.
5 and 6. Eden and MEDVi
Eden at $149/mo and MEDVi at $179 for month one both sit in the mid-range for compounded semaglutide. No contracts from either. Straightforward cash pricing, minimal friction.
7. Found
Found bundles a coaching and platform layer with medication access for roughly $99/mo, with meds billed separately. Good fit if behavioral support alongside the prescription matters to you.
8. Ro Body
Ro Body’s prior-authorization team is genuinely useful if you’re trying to get a branded GLP-1 covered. First month is about $39, then $74 to $149 ongoing, with meds on top.
9. PlushCare
PlushCare’s $19.99 monthly membership is the lowest door-charge here. It runs on branded medications with insurance compatibility and offers same-day appointment slots.
10. Hims & Hers
After the March 2026 Novo Nordisk settlement, Hims & Hers moved away from compounded GLP-1s and onto branded products: injectable Wegovy around $299/mo, oral semaglutide around $249/mo, and Zepbound at roughly $399. With insurance and savings cards the out-of-pocket can drop to near zero. Worth checking if you have coverage.
How to Choose
The monthly number on the homepage tells you very little on its own. Ask who the dispensing pharmacy is, whether purity testing exists, and what happens if your dose needs to change. HealthRX leads here on price-plus-credentialing for cash-pay buyers. FormBlends leads on documented purity and catalog breadth at a higher price. Everyone else fills a real niche somewhere in between.
Common Questions
Is compounded semaglutide from these providers the same drug as Wegovy?
No. Compounded semaglutide is prepared by a 503A pharmacy under pharmacy law, not manufactured by Novo Nordisk. The active molecule is the same, but compounded versions are not FDA-approved and have not gone through the same approval process. That distinction is real and worth understanding before you order.
Which of these providers will tell you exactly which pharmacy compounds your medication?
HealthRX publicly names Manifest Pharmacy in Greer, South Carolina as its 503A dispenser. Most other providers on this list do not disclose their compounding pharmacy by name on their public-facing pages. If that transparency matters to you, ask directly before committing to a subscription.
Does FormBlends’ published purity testing actually mean anything for patient safety?
It means more than nothing. HPLC purity percentages, mass spec identity confirmation, and endotoxin data by batch give you a paper trail that most compounding telehealth brands simply don’t provide. It doesn’t replace FDA approval, but it does let you verify the compound is what it claims to be, which is a meaningful baseline.
After the March 2026 Novo Nordisk settlement, can Hims & Hers still offer compounded GLP-1s?
No. Following that settlement, Hims & Hers shifted to branded products only: Wegovy, oral semaglutide, and Zepbound. If you were using them specifically for lower-cost compounded semaglutide, that option is gone. The branded pricing they now offer can drop significantly with insurance or manufacturer savings cards.
If your insurance denied Wegovy, is Ro Body’s prior-authorization help actually worth trying?
Possibly, depending on your plan. Ro Body has a dedicated prior-auth team, which is more than most cash-pay telehealth services offer. Approval rates vary widely by insurer and diagnosis coding. It costs roughly $39 for the first month to find out, so the financial risk of trying is low compared to a full-price branded prescription.
Sources
- FDA 503A compounding pharmacy framework and 2026 warning letter activity (FDA.gov)
- SURMOUNT-1 trial, tirzepatide, New England Journal of Medicine 2022
- STEP 1 trial, semaglutide, New England Journal of Medicine 2021
- Novo Nordisk settlement announcement, March 9 2026 (public company statements)
- LegitScript compounding pharmacy certification database (LegitScript.com)
- Eli Lilly orforglipron / LillyDirect pricing, April 2026 public announcement
